Motivations for inadequate persistence with disease modifying anti-rheumatic drugs in early rheumatoid arthritis: The patient’s perspective

Knowledge of factors that contribute to non-persistence with disease modifying anti-rheumatic drugs (NP) is essential to improve rheumatoid arthritis (RA) outcomes. Aims of the study were to investigate patient’s motivations and risk factors for NP in a cohort of early RA patients.